MoneyWorks4Me

Transgene Biotech submits copy of limited review report

18 Feb 2013 Evaluate

Transgene Biotech has submitted a copy of the limited review report for the period ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sagility 43.12
Prime Focus 301.65
Knowledge RealtyTrt. 112.24
Indegene 594.00
Syngene Internatl. 360.95
View more..